The skeletal muscle slow myosin heavy chain regulates mammalian metabolic homeostasis through the NRF2 pathway
Science Advances · 2026
DOI: 10.1126/sciadv.aed2478 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Jaydeep Sharma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Developmental Genetics Laboratory, Regional Centre for Biotechnology (RCB), NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway,…. Hauptthemen laut MEDLINE: Myosin Heavy Chains, NF-E2-Related Factor 2, Muscle, Skeletal, Homeostasis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Regional Centre for Biotechnology, Department of Biotechnology, Ministry of Science and Technology, Department of Science and Technology.
Abstract (Originalsprache)
The mammalian skeletal muscle is central to metabolic homeostasis. Myosin heavy chains (MyHCs), key muscle contractile proteins, use energy from adenosine triphosphate hydrolysis to produce mechanical force, fundamental to muscle function. However, the link between MyHCs and metabolic regulation is unclear. Here, we demonstrate the role of Myh7 , encoding the MyHC-slow protein, in regulating skeletal muscle function and metabolic homeostasis using skeletal muscle–specific knockout mice. The absence of MyHC-slow causes early postnatal skeletal muscle hypertrophy followed by atrophy, degeneration of the oxidative slow myofibers, alterations in fiber-type proportions, decreased force production, and muscle dysfunction. It also leads to impaired glucose utilization, insulin resistance, and reduced muscle GLUT4 levels, characteristic of type 2 diabetes. These are mediated through decreased levels of the antioxidant NRF2, elevated reactive oxygen species and mitochondrial dysfunction in the Myh7 knockouts, which can be rescued by activating NRF2 signaling via sulforaphane administration. Our findings link skeletal muscle contractility to metabolic homeostasis, identifying the NRF2 pathway as a key therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Developmental Genetics Laboratory, Regional Centre for Biotechnology (RCB), NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad 121001, Haryana, India.
ORCID-Profile: Jaydeep Sharma, Sam J Mathew
Förderung
- Regional Centre for Biotechnology
- Department of Biotechnology, Ministry of Science and Technology
- Department of Science and Technology
- Council of Scientific and Industrial Research
- Indian Council of Medical Research
Zitieren
APA
Sharma, J., Mondal, S., Rai, A., Kumari, M., Bharadwaj, A., & Mathew, S. J. (2026). The skeletal muscle slow myosin heavy chain regulates mammalian metabolic homeostasis through the NRF2 pathway. Science Advances. https://doi.org/10.1126/sciadv.aed2478
Vancouver
Sharma J, Mondal S, Rai A, Kumari M, Bharadwaj A, Mathew SJ. The skeletal muscle slow myosin heavy chain regulates mammalian metabolic homeostasis through the NRF2 pathway. Science Advances. 2026. doi:10.1126/sciadv.aed2478
BibTeX
@article{Sharma2026,
author = {Sharma, Jaydeep and Mondal, Somnath and Rai, Aparna and Kumari, Mahima and Bharadwaj, Anushree and Mathew, Sam J},
title = {The skeletal muscle slow myosin heavy chain regulates mammalian metabolic homeostasis through the NRF2 pathway},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aed2478}
}
EUVIMED